Taking the brakes off the immune system: modelling effects in non-clinical safety studies
This article focuses on how the immune system functions, the…
This article focuses on how the immune system functions, the challenges that it presents to drug development and why there are such concerns around safety that need to be investigated in pre-clinical studies. Moreover, it covers the role of checkpoint inhibitors as an attractive target for cancer immunotherapy.